Coffee tied to lower Parkinson’s risk — even in those genetically predisposed
By
Alicia Lasek
Oct 05, 2020
People who are predisposed to Parkinson’s may tend to avoid drinking coffee. Alternatively, some mutation carriers may drink a lot of coffee and benefit from its neuroprotective effects, propose investigators.
Clinical briefs for Tuesday, June 15
By
Alicia Lasek
Jun 15, 2021
CMS issues reprieve for 2,500 nursing homes yet to report COVID vaccination rates … Former CMS administrator says nursing homes will remain key test sites for COVID therapies, other treatments …...
Weight for it: High BMI, extra pounds may lead to cardiovascular disease, study says
By
Alicia Lasek
Jun 17, 2019
Investigators have found that excess weight and body fat are a likely cause of cardiovascular disease, not simply associated with it.
Active lifestyle may slow cognitive decline in people with Parkinson’s and dementia gene: study
By
Alicia Lasek
Apr 02, 2021
Greater physical activity at the study’s start appeared to lessen gene-related cognitive decline two years later, the authors report.
Precision aging: Researchers propose a new approach to keep brains healthy, longer
By
Alicia Lasek
Jun 18, 2019
With life spans increasing, it may be time to discard a one-size-fits-all approach to brain health. A group of researchers propose a new precision medicine model.
The coronavirus likely began to spread worldwide last year, say researchers
By
Alicia Lasek
May 06, 2020
The pandemic may have started as early as October 2019, quickly adapting to its human host, according to a new genetic analysis.
Monoclonal antibodies cut COVID-19 hospitalizations in high-risk adults: Mayo Clinic
By
Alicia Lasek
Jul 22, 2021
Patients treated early in the disease with either one of two antibody therapies had similarly low rates of hospitalization within 28 days.
FDA approves first generic of glucagon to treat severe low blood sugar
By
Alicia Lasek
Jan 04, 2021
Glucagon to treat severe hypoglycemia is available in a generic formula for the first time in 20 years.
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
Clinical Briefs for Wednesday, July 22
By
Alicia Lasek
Jul 22, 2020
ICU study finds new COVID-19 mortality factors, wide variation in supportive care … Poor cardiovascular health and genetics jointly contribute to dementia risk … Genetic testing could help predict...